Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 7, 2024

Total Value ($000): $335,237 (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 73.1%

Value ($000) $244,970 Shares 6,068,125 Est. Cost $40.43 Unrealized -25.7%

— Verona Pharma plc (VRNA) 6.6%

Value ($000) $22,173 Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 6.6%

Value ($000) $22,150 Shares 1,025,000 Est. Cost $10.24 Unrealized +50.1%

BMEA Biomea Fusion Inc (BMEA) 3.5%

Value ($000) $11,598 Shares 798,757 Est. Cost $17.65 Unrealized -31.2%

CMPS Compass Pathways Plc (CMPS) 2.5%

Value ($000) $8,439 Shares 964,500 Est. Cost $7.40 Unrealized —

GLUE Monte Rosa Therapeutics Inc (GLUE) 2.5%

Value ($000) $8,319 Shares 1,472,331 Est. Cost $20.37 Unrealized -80.7%

NUVB Nuvation Bio Inc. (NUVB) 1.1%

Value ($000) $3,837 Shares 2,541,009 Est. Cost $11.18 Unrealized -88.5%

— Spruce Biosciences, Inc. (SPRB) 1.1%

Value ($000) $3,532 Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.0%

Value ($000) $3,505 Shares 1,043,267 Est. Cost $8.87 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.5%

Value ($000) $1,729 Shares 314,286 Est. Cost $1.74 Unrealized +95.0%

— Elevation Oncology Inc (ELEV) 0.5%

Value ($000) $1,522 Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Reneo Pharmaceuticals Inc (RPHM) 0.4%

Value ($000) $1,418 Shares 886,075 Est. Cost $9.33 Unrealized —

— Avrobio, Inc. (AVRO) 0.4%

Value ($000) $1,373 Shares 1,009,779 Est. Cost $16.72 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.1%

Value ($000) $456 Shares 434,455 Est. Cost $10.31 Unrealized -70.4%

— Viracta Therapeutics Inc (VIRX) 0.0%

Value ($000) $164 Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.0%

Value ($000) $51 Shares 387,653 Est. Cost $18.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$244,970	73.1%	$40.43	-25.7%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$22,173	6.6%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$22,150	6.6%	$10.24	+50.1%	COM	87164F105
BMEA	Biomea Fusion Inc (BMEA)	798,757	$11,598	3.5%	$17.65	-31.2%	COM	09077A106
CMPS	Compass Pathways Plc (CMPS)	964,500	$8,439	2.5%	$7.40	—	SPONSORED ADS	20451W101
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$8,319	2.5%	$20.37	-80.7%	COM	61225M102
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$3,837	1.1%	$11.18	-88.5%	COM CL A	67080N101
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$3,532	1.1%	$24.31	—	COM	85209E109
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$3,505	1.0%	$8.87	—	COM	73730P108
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$1,729	0.5%	$1.74	+95.0%	COM	57055L206
—	Elevation Oncology Inc (ELEV)	2,834,910	$1,522	0.5%	$13.57	—	COM	28623U101
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$1,418	0.4%	$9.33	—	COM	75974E103
—	Avrobio, Inc. (AVRO)	1,009,779	$1,373	0.4%	$16.72	—	COM	05455M100
ACRS	Aclaris Theraputics Inc (ACRS)	434,455	$456	0.1%	$10.31	-70.4%	COM	00461U105
—	Viracta Therapeutics Inc (VIRX)	288,571	$164	0.0%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$51	0.0%	$18.84	—	CL A COM	04965G109